IOVS Journal of Nutrition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ham, D.-I.
Right arrow Articles by Gery, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ham, D.-I.
Right arrow Articles by Gery, I.
(Investigative Ophthalmology and Visual Science. 2002;43:2258-2263.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

RPE65 Is Highly Uveitogenic in Rats

Don-Il Ham1,2, Susan Gentleman3, Chi-Chao Chan1, J. Hugh McDowell4, T. Michael Redmond3 and Igal Gery1

1 From the Laboratories of Immunology and 3 Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland; the 2 Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; and the 4 Department of Ophthalmology, University of Florida, Gainesville, Florida.

PURPOSE. To examine the hypothesis that RPE65, a protein specific to the retinal pigment epithelium, is uveitogenic in rats.

METHODS. Rats of four inbred strains (Lewis, Brown Norway, Fischer, and SHR) were immunized with native or recombinant bovine RPE65, or with S-antigen (S-Ag), emulsified with complete Freund adjuvant, and treated simultaneously with killed Bordetella pertussis bacteria, as indicated. Development of ocular changes was examined and scored both clinically and histologically.

RESULTS. Lewis rats immunized with RPE65 showed development of acute and severe inflammatory eye disease that affected most ocular tissues. The minimum uveitogenic dose of RPE65 was similar to that of S-Ag (1 µg per rat), but the changes induced by RPE65 at higher dose ranges were less severe than those induced by S-Ag. Concurrent treatment of the RPE65-immunized rats with B. pertussis bacteria was not critical for disease induction, but enhanced dramatically the pathogenic reaction. Unlike the results with several other retinal proteins, no pinealitis was detected in rats immunized with RPE65. Fischer (F344) rats resembled Lewis rats in being similarly affected by RPE65 or S-Ag. In contrast, Brown Norway (BN) rats developed severe disease when immunized with RPE65, but showed minimal changes in response to S-Ag. SHR rats responded poorly to disease induced by RPE65, and S-Ag-induced disease failed to develop.

CONCLUSIONS. RPE65 is highly uveitogenic in rats, thus suggesting that this molecule could be involved in pathogenic autoimmunity in the human eye.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Z. Li, B. Liu, A. Maminishkis, S. P. Mahesh, S. Yeh, J. Lew, W. K. Lim, H. N. Sen, G. Clarke, R. Buggage, et al.
Gene Expression Profiling in Autoimmune Noninfectious Uveitis Disease
J. Immunol., October 1, 2008; 181(7): 5147 - 5157.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Takase, C.-R. Yu, R. M. Mahdi, D. C. Douek, G. B. DiRusso, F. M. Midgley, R. Dogra, G. Allende, E. Rosenkranz, A. Pugliese, et al.
Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals
Int. Immunol., August 1, 2005; 17(8): 1131 - 1140.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Narfstrom, M. L. Katz, R. Bragadottir, M. Seeliger, A. Boulanger, T. M. Redmond, L. Caro, C.-M. Lai, and P. E. Rakoczy
Functional and Structural Recovery of the Retina after Gene Therapy in the RPE65 Null Mutation Dog
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1663 - 1672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology